Hjem › Hypofarynxcancer › Illinois › Springfield
Kliniske studier for Hypofarynxcancer i Springfield, IL
3 studier for Hypofarynxcancer søker deltakere på steder i og rundt Springfield (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Hypofarynxcancer-studier i andre byer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Kansas City, MO5 studier
- Richmond, VA5 studier
- Wausau, WI5 studier
- Bloomington, IL5 studier
- Stevens Point, WI5 studier
- Cape Girardeau, MO5 studier
- Peoria, IL5 studier
- Milwaukee, WI5 studier
- Joliet, IL5 studier
- Overland Park, KS4 studier
Andre studier i Springfield
- Ikke-småcellet lungekreft13 studier
- Lungekreft12 studier
- Kolorektal kreft9 studier
- Brystkreft8 studier
- Akut myelogen leukemi8 studier
- Kreft (alle typer)6 studier
- Blærekreft6 studier
- Prostatakreft6 studier
- Plateepitelcancer i hode og hals6 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Pankreaskreft5 studier
- Melanom5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.